Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET) Total Liabilities (2016 - 2026)

Metlife's Total Liabilities history spans 18 years, with the latest figure at $715.4 billion for Q1 2026.

  • Quarterly Total Liabilities rose 8.3% to $715.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $715.4 billion through Mar 2026, up 8.3% year-over-year, with the annual reading at $716.2 billion for FY2025, 10.23% up from the prior year.
  • Total Liabilities came in at $715.4 billion for Q1 2026, roughly flat from $716.2 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $716.2 billion in Q4 2025 to a low of $624.8 billion in Q3 2022.
  • The 5-year median for Total Liabilities is $649.8 billion (2024), against an average of $659.0 billion.
  • Year-over-year, Total Liabilities decreased 11.13% in 2022 and then grew 10.23% in 2025.
  • Metlife's Total Liabilities stood at $632.9 billion in 2022, then rose by 3.85% to $657.3 billion in 2023, then fell by 1.15% to $649.8 billion in 2024, then grew by 10.23% to $716.2 billion in 2025, then decreased by 0.12% to $715.4 billion in 2026.
  • Per Business Quant, the three most recent readings for MET's Total Liabilities are $715.4 billion (Q1 2026), $716.2 billion (Q4 2025), and $690.5 billion (Q3 2025).